Bruker Corporation (BRKR)

$53.93

up-down-arrow $-1.26 (-2.27%)

As on 12-Jun-2026 13:36EDT

Market cap

info icon

$8,584 Mln

Revenue (TTM)

info icon

$3,459 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

3.5

Div. Yield

info icon

0.3 %

Bruker (BRKR) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 52.90 High: 55.07

52 Week Range

Low: 28.53 High: 64.54

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    50.52

  • EV/EBITDAEV/EBITDA information

    33

  • Debt to EquityDebt to Equity information

    0.7

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    152,225,624

10 Years Aggregate

CFO

$2,309.50 Mln

EBITDA

$3,741.20 Mln

Net Profit

$1,926.10 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Bruker (BRKR)
14.5 24.6 46.5 35.8 -10.3 -6.0 8.1
BSE Sensex
-10.8 -0.6 -1.7 -8.5 6.4 7.6 11.0
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 12-Jun-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Bruker (BRKR)
-19.6 -20.1 7.5 -18.5 55.0 6.2 71.2
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Bruker (BRKR)
53.9 8,584.0 3,458.5 -11.6 2.6 -0.6 -- 3.5
87.9 158,626.9 45,134.0 6,276.0 15.4 12.2 25.5 3.0
47.0 70,111.4 20,615.0 3,553.0 19.9 14.5 19.7 2.8
180.3 127,957.8 24,778.0 3,689.0 18.7 7.1 35.1 2.4
84.8 49,495.8 6,303.5 1,092.8 12.7 10.6 46.5 4.9
557.9 44,344.9 4,446.1 1,095.2 23.5 70.3 41.3 28.5
408.4 149,478.0 10,582.1 2,979.1 22.4 17.2 51.3 8.6
80.4 103,134.5 36,364.0 4,800.0 13.3 19.6 21.5 2.1
313.8 117,170.4 25,270.0 3,337.0 18.5 15.1 35.3 5.1
470.3 176,765.5 45,197.0 6,859.0 19.2 13.3 26.2 3.4

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Bruker (BRKR)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID,...  BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts. 

  • Chairman, CEO & President

    Dr. Frank H. Laukien Ph.D.

  • Chairman, CEO & President

    Dr. Frank H. Laukien Ph.D.

  • Headquarters

    Billerica, MA

  • Website

    https://www.bruker.com

Edit peer-selector-edit
loading...
loading...

FAQs for Bruker (BRKR)

The share price of Bruker Corporation (BRKR) is $53.93 (NASDAQ) as of 12-Jun-2026 13:36 EDT. Bruker Corporation (BRKR) has given a return of -10.33% in the last 3 years.

Since, TTM earnings of Bruker Corporation (BRKR) is negative, P/E ratio is not available.
The P/B ratio of Bruker Corporation (BRKR) is 3.51 times as on 05-Jun-2026, a 4 premium to its peers’ median range of 3.38 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-835.38
2.92
2024
78.78
5.00
2023
25.11
7.79
2022
34.08
9.08
2021
46.18
11.95

The 52-week high and low of Bruker Corporation (BRKR) are Rs 64.54 and Rs 28.53 as of 13-Jun-2026.

Bruker Corporation (BRKR) has a market capitalisation of $ 8,584 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Bruker Corporation (BRKR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.